Table 1 Primary Prevention Research, n = 89

Primary Prevention

HPV Vaccination

Knowledge/Acceptability/Attitudes

(N = 29)

25 Original research [39–41, 126, 127, 130–132, 134–137, 139, 144–151, 158, 180, 256, 257]

2 Review Articles [12, 15]

0 Lessons Learned

2 Policy Papers [167, 258]

Tanzania [126, 180], Uganda [40, 127], Nigeria [131, 137, 256], South Africa [130, 139, 148, 150, 151, 158], Malawi [41], Mali [132, 147], Cameroon [134, 144], Kenya [39, 145, 257], Botswana [135], Ghana [136], Zambia [146], Morocco [149]

Uptake/Retention (N = 10)

6 Original research [43, 153, 155, 157, 159, 160]

1 Review Articles [259]

3 Lessons Learned [154, 156, 260]

0 Policy

Uganda [153, 259, 261], Lesotho [43, 155], Cameroon [43, 155, 156], Tanzania [155, 160], Uganda [155, 157], Kenya [155], South Africa [159], Rwanda [154, 260]

Feasibility (N = 23)

 Cost/cost effectiveness [14, 170, 181, 214, 261–269]

 Estimated impact [270–272]

 Provider knowledge/training [128, 129, 133, 140–143]

21 Original research [128, 129, 133, 140–143, 170, 181, 214, 261, 263–272]

2 Review Articles [14, 262]

0 Lessons Learned

0 Policy

Tanzania [14, 181, 267, 269], Uganda [14, 267, 271], Sub-Saharan Africa [262, 264], Mali [263, 270], Nigeria [128, 140, 141, 143, 265], South Africa [129, 142, 214], GAVI-eligible countries [266, 268, 272], Kenya [267, 271], Mozambique [271], Zimbabwe [271], Guinea [170], Cameroon [133]

HIV (N = 2)

2 Original research [161, 162]

0 Review Articles

0 Lessons Learned

0 Policy

South Africa [161, 162]

Males (N = 1)

1 Original research [138]

0 Review Articles

0 Lessons Learned

0 Policy

Uganda [138]

Other (N = 11)

 Safety/Immunogenicity (n = 2) [164, 165]

 Adverse Events (n = 1) [166], Barriers (n = 1) [42], Policy (n = 6) [168, 169, 273–276], Conference Summary (n = 1) [152]

3 Original research [164–166]

2 Review Articles [42, 152]

0 Lessons Learned

6 Policy [168, 169, 273–276]

Uganda [166, 168, 274], Senegal [164], Tanzania [164, 165], Low-Middle Income Countries [42, 273, 276], Middle East/North Africa [275], Sub-Saharan Africa [152, 169]

Primary Prevention (HPV Vaccine)

Total = 76

59 Original research

6 Review Articles

3 Lessons Learned

8 Policy

South Africa 12, Uganda 12, Tanzania 10, Nigeria 8, Cameroon 6, Kenya 6, Mali 4, Low-Middle Income Countries 3, GAVI Eligible Countries 3, Lesotho 2, Rwanda 2, sub-Saharan Africa 4, Malawi 1, Botswana 1, Ghana 1, Zambia 1, Morocco 1, Ivory Coast 1, Mozambique 1, Zimbabwe 1, Middle East/North Africa 1, Guinea 1

Non-Vaccine Prevention

Male Circumcision (N = 10)

10 Original research [46–48, 171–176, 277]

0 Review Articles

0 Lessons Learned

0 Policy

Uganda [47, 48, 171–174, 176, 277], South Africa [46, 175]

Condoms (N = 1)

1 Original research [179]

0 Review Articles

0 Lessons Learned

0 Policy

South Africa [179]

Lubricant Gel, Microbicides and/or Diaphragm (N = 2)

2 Original research [177, 178]

0 Review Articles

0 Lessons Learned

0 Policy

South Africa [178], Zimbabwe [177]

Primary Prevention (Non-Vaccine)

Total = 13

13 Original research

Uganda (8), South Africa (4), Zimbabwe (1)